One solution to this shortage is the use of living donors for liver transplantation. (sciencedaily.com)
This study is to evaluate use of everolimus and tacrolimus in a prospective manner to see if the use of these two medications results in lower tumor recurrence and better patient survival than tacrolimus and mycophenolic acid / mycophenolate mofetil after liver transplantation for HCC. (pennmedicine.org)
According to the researchers, BA affects one out of 14,000 children in the United States and is the leading cause of liver transplantation in children. (sciencemag.org)